Portfolio Update

Finsbury Worldwide Pharm Tst PLC
05 January 2005

                                                                  5 January 2005


                    FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
                                   (the 'Company')

                         QUARTERLY STATEMENT OF INVESTMENTS


In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii),
the Company discloses the following:

  • Investments valuing greater than 5% of the Company's gross assets comprise
    the following:


Company Name                                                        Value of Investment at      % of Total
                                                                      31 December 2004       Portfolio Assets

Pfizer Com                                                                22,405,334               7.71
Novartis                                                                  17,584,738               6.05
Genentech Inc                                                             16,155,295               5.56
Altana AG                                                                 15,080,765               5.19
Genzyme Corp General Division                                             14,669,488               5.05




  • The ten largest investments held by the Company comprise the following:

Company Name                                                         Value of Investment at      % of Total
                                                                       31 December 2004       Portfolio Assets

Pfizer Com                                                                 22,405,334               7.71
Novartis                                                                   17,584,738               6.05
Genentech Inc                                                              16,155,295               5.56
Altana AG                                                                  15,080,765               5.19
Genzyme Corp General Division                                              14,669,488               5.05
Amgen                                                                      14,201,716               4.89
Lilly (Eli) & Company                                                      12,415,803               4.27
Biogen Idec Com                                                            11,622,663               4.00
Takeda Pharmaceutical                                                      11,376,254               3.91
Schering-Plough Corporation                                                10,865,149               3.74



                                    - ENDS -



For further information please contact:

Tracey Lago, Company Secretary
Close Finsbury Asset Management Limited
Telephone: [phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange